Fermenta Biotech, one of India’s leading manufacturers of APIs, intermediates, and nutritional premixes, has been granted a patent by the Indian Patent Office for its proprietary process to produce plant-based Vitamin D3.   

The newly granted patent strengthens Fermenta’s intellectual property (IP) portfolio and reinforces its leadership in sustainable Vitamin D3 solutions.  

The invention enables the production of fully vegan and vegetarian-friendly Vitamin D3, addressing the accelerating global demand for ethically sourced, sustainable nutrition.

The company said the development opens new opportunities across nutraceuticals and food fortification sectors, where sustainable, plant-derived ingredients command premiums and growing market share.

Prashant Nagre, Managing Director of Fermenta, said, “The grant of this patent is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions. Plant-based Vitamin D3 represents the future of nutrition, and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India’s role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness.”

With a presence in over 60 countries, Fermenta supplies products for pharmaceuticals, dietary supplements, food, animal nutrition, and rodenticides. Its manufacturing facilities in Kullu, Dahej, and Tirupati are accredited by global certifications, supported by a world-class R&D centre in Thane.